Journal article
Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation
The EMBO journal, Vol.33(17), pp.1960-1976
09/01/2014
DOI: 10.15252/embj.201487826
PMCID: PMC4195789
PMID: 25024437
Abstract
The antimitotic anti-cancer drugs, including taxol, perturb spindle dynamics, and induce prolonged, spindle checkpoint-dependent mitotic arrest in cancer cells. These cells then either undergo apoptosis triggered by the intrinsic mitochondrial pathway or exit mitosis without proper cell division in an adaptation pathway. Using a genome-wide small interfering RNA (siRNA) screen in taxol-treated HeLa cells, we systematically identify components of the mitotic apoptosis and adaptation pathways. We show that the Mad2 inhibitor p31(comet) actively promotes mitotic adaptation through cyclin B1 degradation and has a minor separate function in suppressing apoptosis. Conversely, the pro-apoptotic Bcl2 family member, Noxa, is a critical initiator of mitotic cell death. Unexpectedly, the upstream components of the mitochondrial apoptosis pathway and the mitochondrial fission protein Drp1 contribute to mitotic adaption. Our results reveal crosstalk between the apoptosis and adaptation pathways during mitotic arrest.
Details
- Title: Subtitle
- Genome-wide siRNA screen reveals coupling between mitotic apoptosis and adaptation
- Creators
- Laura A Díaz-Martínez - Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USAZemfira N Karamysheva - Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USARoss Warrington - Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USABing Li - Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USAShuguang Wei - Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USAXian-Jin Xie - Center for Biostatistics and Clinical Science, University of Texas Southwestern Medical Center, Dallas, TX, USAMichael G Roth - Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX, USAHongtao Yu - Department of Pharmacology, Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA hongtao.yu@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- The EMBO journal, Vol.33(17), pp.1960-1976
- DOI
- 10.15252/embj.201487826
- PMID
- 25024437
- PMCID
- PMC4195789
- NLM abbreviation
- EMBO J
- ISSN
- 1460-2075
- eISSN
- 1460-2075
- Publisher
- England
- Grant note
- R01CA125269 / NCI NIH HHS R01 CA125269 / NCI NIH HHS Howard Hughes Medical Institute
- Language
- English
- Date published
- 09/01/2014
- Academic Unit
- Preventive and Community Dentistry; Biostatistics; Dental Research
- Record Identifier
- 9983917771802771
Metrics
30 Record Views